Material Composition: 100% Homopolymer Polydioxanone. ISO 10993 certified biocompatibility. Total hydrolysis into CO2 and H2O within 180-210 days.

Dimensional Specs: 30G Gauge (0.29mm – 0.33mm outer diameter). 25mm-30mm lengths. Ultra-thin wall L-Type sharp needle profile.

Tensile Metrics: ≥2.8N tensile strength. Resists premature structural failure during multi-vector facial insertion.

Clinical Efficacy: Documented 84.2% neocollagenesis (Type I & III ratio enhancement) evaluated at week 12. Endogenous fibroblasts proliferation triggered within 48 hours post-insertion.

Standardized Implantation Protocol

01 Prep: Sterilize target dermis utilizing 0.5% Chlorhexidine solution. Topographical mapping at 5.0mm ± 1.0mm grid intervals.

02 Trajectory: Fixate needle at 25°-30° angle. Execute subdermal deployment at strictly 1.5mm-2.0mm depth. Avert Superficial Musculoaponeurotic System (SMAS) penetration.

03 Post-Op: Immediate 15-minute cryotherapy compress. Prohibit rigorous mastication, aggressive cleansing, and Radiofrequency (RF) procedures for 4 weeks.